ENTITY
SanBio Co Ltd

SanBio Co Ltd (4592 JP)

57
Analysis
Health Care • Japan
Sanbio Co Ltd researches, develops, manufactures, and sells regenerative cell re lated pharmaceutical products.
more
•24 Sep 2018 17:36

Japan Fortnightly Update: Celebration

APATHY STRIKES AGAINTHE APATHY INDICATOR - Our Fortnightly Update for 26th August highlighted the lack of market activity after the end of the...

Logo
480 Views
Share
•26 Aug 2018 16:31

Japan Fortnightly Update: Turning Point

TURNING POINT - Despite the last four trading days being 'up', the Japanese equity market composite fell by 0.6% over the last two weeks. New...

Logo
606 Views
Share
•28 May 2018 18:08

Japan: Scoring Results & Forecasts - Part 3 - Company Winners & Losers

INTRODUCTION - The final part of our Results and Forecast/Revision Scores review will look at the leading and lagging performers and forecasters...

Logo
482 Views
Share
bullish•SanBio Co Ltd
•22 Sep 2025 08:30

SanBio Co Ltd (4592 JP): Akuugo Approval Awaited; Plans Negotiation for Ischemic Stroke Trials

​SanBio revised FY26 operating loss guidance to reflect higher manufacturing expenses to secure the inventory necessary for future clinical trials...

Logo
396 Views
Share
bullish•SanBio Co Ltd
•18 Jun 2025 17:21

SanBio Co Ltd (4592 JP): Akuugo Shipments Expected To Commence In 2QFY26, New Credit Line In Place

SanBio reports Q1FY26 result. Higher R&D expenses (¥ 723M) and foreign exchange losses (¥ 711M) led to a net loss of ¥ 1,531M (vs ¥ 144M in...

Logo
1.1k Views
Share
x